CYOE CytoCore, Inc. featured news, full reports, and detailed charts
CytoCore, Inc. (CYOE/CYOE.OB) Wrap Up:
CytoCore, Inc., a clinical diagnostics company, engages in the design, development, and commercialization of screening, diagnostic, and therapeutic-delivery products that are used in women’s healthcare. Its screening and diagnostic systems are used for detection of gynecological cancers and sexually transmitted diseases. The company offers CytoCore Solutions system, which provides a noninvasive screening test for the detection of cervical, endometrial, and other cancers, as well as the human Papilloma virus. The CytoCore Solutions system includes SoftPAP cervical cell collection device; Cocktail-CVX and Cocktail-GCI, which are biochemical assays used to identify suspicious and abnormal cells...www.cytocoreinc.com
9 Employees
CytoCore, Inc. (CYOE:OTC Bulletin Board Market)
LAST $0.16 USD
CHANGE TODAY -0.02 -11.11%
VOLUME 49.0K
As of 3:59 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of CytoCore, Inc. (CYOE)
|
OPEN
$0.16
|
PREVIOUS CLOSE
$0.18
|
|
|
DAY HIGH
$0.18
|
DAY LOW
$0.14
|
|
|
52 WEEK HIGH
01/5/09 - $0.84
|
52 WEEK LOW
09/10/09 - $0.08
|
|
|
MARKET CAP
6.7M
|
AVERAGE VOLUME 3 mo
55.2K
|
|
|
DILUTED EPS TTM
$-0.14
|
SHARES OUTSTANDING
42.2M
|
|
|
CYOE Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
CYOE Top Compensated Officers
Mr. Robert F. McCullough Jr.
Chairman, Chief Executive Officer, Chief Fina...
Age: 54
Total Annual Compensation: $180.0K
Dr. Richard A. Domanik Ph.D.
Chief Operating Officer
Age: 62
Total Annual Compensation: $145.0K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for CytoCore, Inc. (CYOE)
CytoCore, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2009
08/20/2009
CytoCore, Inc. reported earnings results for the second quarter ended June 30, 2009. The company reported net loss for the quarter was $3.02 million, up from $3.58 million for the same quarter the previous year.
CytoCore, Inc. announced delayed 10-Q filing
08/17/2009
On 08/17/2009, CytoCore, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
CytoCore, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2009
05/19/2009
CytoCore, Inc. announced earnings results for the first quarter ended March 31, 2009. For the quarter, the company reported net loss of $1.93 million. In contrast, the company posted a net loss of $1.89 million for the same quarter in the previous year.
CYOE Competitors
| Company | Last | Change |
| Clarient Inc | $2.47 USD | -0.06 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CYOE | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 101.6x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 71.5x |
|
|
CYOE |
||
|
CYOE transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About CytoCore, Inc.
Would you like to leave a comment about CytoCore, Inc. CYOE/CYOE.OB
Find out what social network information about CytoCore, Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides CytoCore, Inc. there is more great information available at Realpennies.com